FDA OKs Guselkumab for Crohn’s Disease ...Middle East

Medscape - News
FDA OKs Guselkumab for Crohn’s Disease
Guselkumab is the first and only interleukin-23 inhibitor that offers both subcutaneous and intravenous induction options for moderately to severely active Crohn’s disease. Medscape Medical News

Hence then, the article about fda oks guselkumab for crohn s disease was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA OKs Guselkumab for Crohn’s Disease )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News